证券日报网讯2月3日，爱美客（300896）在互动平台回答投资者提问时表示，维护市值稳定的核心，在 于持续提升公司的内在价值与经营业绩。公司将持续聚焦主业发展，通过优化经营策略等切实举措提升 经营业绩，维护全体股东的长远利益。 ...

证券日报网讯 2月3日，爱美客在互动平台回答投资者提问时表示，公司始终聚焦主业，提升核心价 值，以此增强股东信心。 （文章来源：证券日报） ...

（编辑 楚丽君） 证券日报网讯 2月3日，爱美客在互动平台回答投资者提问时表示，公司一直重视财务健康状况，通过 提升运营效率、优化资本结构、加强现金流管理等措施，不断增强财务稳健性，稳步提升经营业绩水 平，加强投资者信心。 ...

Group 1 - The core viewpoint of the article is that Aimeike has reported an increase in inventory as of September 30, 2025, attributed to an expansion in the scope of consolidation [2] Group 2 - As of September 30, 2025, the company's inventory stands at 96,447,368.31 yuan, reflecting a growth of 32.40% compared to December 31, 2024 [2]

证券日报网讯2月3日，爱美客（300896）在互动平台回答投资者提问时表示，公司经过多年的发展，与 下游客户形成稳定的合作体系，公司通过持续赋能、效率提升等多方面与合作伙伴共筑行业生态，优化 经营策略，以灵活的经营策略和市场化的应对机制应对行业变化，促进行业的长期可持续发展。 ...

证券日报网讯2月3日，爱美客（300896）在互动平台回答投资者提问时表示，股价波动受宏观经济、市 场环境、投资者情绪等多种因素影响。公司一直重视市值管理工作，持续聚焦主业发展，不断提高管理 水平、增强研发实力，同时通过规范运作，提升公司治理能力，努力通过稳健的业绩成长和价值创造回 报投资者。 ...

Core Viewpoint - The decline of the beauty economy is a significant shift in societal values, indicating that reliance on physical appearance for income is becoming unsustainable, leading to a need for women to focus on skills and professional development instead of beauty-based monetization [3][18][19] Group 1: Decline of the Beauty Economy - The beauty economy is experiencing a near-collapse, with both online and offline sectors facing severe downturns, as evidenced by a 77% drop in nightclub traffic and a 60% decline in bar attendance in 2025 [4][5] - The medical aesthetics industry is also suffering, with nearly 40% of small clinics closing due to tightened credit for beauty loans, leading to a significant increase in overdue loans among women [5][6] - The willingness of men to spend on beauty-related services and products is rapidly decreasing, as shown by a 41% drop in online flower sales during the 2025 520 festival and a 40% decline in high-end dining orders [6][7] Group 2: Factors Contributing to the Collapse - The tightening of regulations against low-quality online content and the economic downturn are primary factors contributing to the decline of the beauty economy, as consumers cut back on non-essential spending [7][8] - Market saturation and aesthetic fatigue have accelerated the collapse, with an oversupply of similar beauty influencers leading to diminished consumer interest [8][9] - The awakening of women's self-awareness and independence is driving a shift away from valuing beauty as a primary asset, with many women now focusing on skill development and professional growth [9][11] Group 3: New Opportunities for Women - The collapse of the beauty economy presents an opportunity for women to redefine their career paths by combining beauty with professional skills, as evidenced by successful transitions of former beauty influencers into academic or specialized roles [11][12] - Women are increasingly entering traditionally male-dominated fields such as technology and construction, with a notable rise in the employment rate of skilled female workers compared to those relying solely on beauty [12][13] - Embracing entrepreneurship in niche markets, such as skincare or second-hand luxury goods, is becoming a viable option for women, with the second-hand luxury market projected to grow significantly [12][13] Group 4: Lessons for Men - The decline of the beauty economy serves as a warning for men to reassess their consumption habits and recognize the value of women beyond physical appearance [15][16] - Men are encouraged to focus on personal growth and responsible spending, moving away from emotional consumption patterns that have previously supported the beauty economy [16][17] - The importance of developing diverse skills and taking on responsibilities is emphasized, as reliance on a single advantage is no longer sufficient in a competitive environment [17][18]

Core Viewpoint - The collaboration between medical beauty brands and "villains" signifies a shift in brand communication, aiming to inject confidence and vitality into the traditionally anxiety-ridden medical beauty marketing landscape [4][6]. Group 1: Industry Overview - The medical beauty industry in China has been characterized by a scarcity of quality and affordable services, leading to information asymmetry and regulatory gray areas that complicate consumer decision-making [9][10]. - Traditional medical beauty institutions often struggle with scalability, as many have been operating for over twenty years with limited store counts, typically between 20 to 40 [6][10]. - The industry is transitioning from a seller's market to a buyer's market due to an increase in product approvals, which is expected to enhance competition and reduce product scarcity [11][12]. Group 2: Company Development - New Oxygen has opened 50 direct-operated clinics across 16 cities and completed over 1 million treatments, positioning itself as a leader in the light medical beauty chain brand sector in China [5][4]. - The company has established the "Youth Selection Alliance," which sets stringent standards for product quality and aims to redefine what constitutes a "good product" in the market [15][16]. - New Oxygen's approach includes a focus on building a scalable and high-quality delivery system to address the industry's challenges of trust and efficiency [7][12]. Group 3: Supply Chain and Market Dynamics - The "Youth Selection Alliance" allows New Oxygen to leverage its treatment volume to negotiate better terms with suppliers, ensuring high-quality products are available to consumers [16][18]. - The company has formed partnerships with major pharmaceutical and medical beauty suppliers, significantly increasing its purchasing power and market influence [17][18]. - New Oxygen's strategy emphasizes the importance of a robust supply chain and efficient distribution channels, which are critical for driving down costs and enhancing product availability [20][21]. Group 4: Future Outlook - The transformation within the medical beauty industry is expected to lead to a healthier ecosystem and a more rational consumer market, characterized by increased choice, transparency, and trust [27][28]. - As the industry moves towards full market competition, companies that can effectively balance consumer trust and supply chain efficiency will thrive [27][28]. - New Oxygen's ongoing efforts to integrate technology and streamline operations are essential for overcoming existing industry challenges and achieving sustainable growth [22][28].

Core Viewpoint - Recently, the new specifications of the polylactic acid facial filler (commonly known as "youthful needle") developed by Sihuan Pharmaceutical's Meiyan Space have been officially approved by the National Medical Products Administration, further enriching the aesthetic medicine product pipeline [1] Group 1: Company Strengths - Sihuan Pharmaceutical is positioned as a leading player in China's aesthetic medicine industry, leveraging a comprehensive product matrix to create a competitive barrier, a robust channel network to solidify market foundations, and a revenue scale that outpaces the industry [1][10] - The company has established a full-category product layout, being the first in the industry to cover five core categories, thus creating a strong product barrier [4] - The company has a nationwide coverage of nearly 8,000 aesthetic medicine institutions and has established deep partnerships with over 230 leading groups and regional core institutions, showcasing a resilient "direct + agency" channel model [5] Group 2: Financial Performance - In the first half of 2025, Sihuan Pharmaceutical's aesthetic medicine business achieved revenue of 580 million yuan, representing a year-on-year growth of 81.3%, demonstrating its leading position in the industry [7][13] - The company has completed 35 dividend distributions since its listing, with a total dividend amount exceeding 7.8 billion yuan, alongside nearly 3.9 billion yuan in cash reserves, indicating a favorable low valuation, high growth, and high dividend profile [13] Group 3: Research and Development - Sihuan Pharmaceutical is increasing its investment in R&D within the aesthetic medicine sector, with plans to launch three significant Class III medical devices in 2025, including the youthful needle and the girl needle, which are expected to support future revenue growth [8] Group 4: Brand and Compliance - The company adheres to GMP standards in product development and production, enhancing its brand's academic attributes through hosting academic conferences and training for doctors, thereby strengthening its professional brand image [9]

Investment Rating - The report maintains a "Recommended" investment rating for the beauty and personal care industry [5][26]. Core Insights - Betaini Group's brand Winona has officially entered the Middle East market, expanding its overseas footprint by opening its first offline store in Doha Mall, Qatar, marking it as the first Chinese functional skincare brand registered in Qatar [5][24]. - The report highlights the global development strategy of companies in the medical beauty sector, emphasizing a transition from single product output to a systematic compliance layout and the value output of "Chinese solutions" [5][26]. - The report suggests focusing on companies with core raw material technology advantages and a full industry chain matrix, such as Marubi Biotechnology, Huaxi Biological, and Juzhi Biological [5][26]. Summary by Sections Recent Market Performance - From January 26 to January 30, 2026, the Shenwan Beauty and Personal Care Index decreased by 3.92% [13]. - The top five gainers in the sector included companies like Four Seasons Medicine and Yisi Health, while the biggest losers included Lafang Cosmetics and Shanghai Jahwa [13]. Industry News - Time安生物's siRNA weight loss drug targeting ALK7 has achieved global simultaneous submission for clinical trials, showcasing the company's global development strategy [18][19]. - The customs authority has introduced nine measures to support the development of the beauty industry, focusing on building Guangzhou as a global cosmetics manufacturing and consumption center [20]. Key Company Announcements - Baiya Co., Ltd. announced plans for share reduction by major shareholders, while Jeya Co., Ltd. plans to recognize asset impairment losses to reflect its financial status accurately [21][22]. Weekly Insights - The opening of Winona's store in Qatar is a significant step in the brand's globalization strategy, receiving recognition from local medical and retail sectors [24][25]. - The report emphasizes the importance of systematic compliance capabilities and clinical validation in the development of medical beauty enterprises [26]. Investment Recommendations - The report recommends focusing on companies with strong R&D capabilities and market positioning, such as Betaini and Aimeike, while also considering traditional brands that are actively transforming [26].